10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q3 2017

Filing Information

Form Type	10-Q
Accession Number	`0001144204-17-055799`
Period End Date	20170930
Filing Date	20171102
Fiscal Year	2017
Fiscal Period	Q3
XBRL Instance	iova-20170930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 42 Income Statement 44 Cash Flow Statement 63 Comprehensive Income 12

Balance Sheet 42 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.72M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$163.38M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$92.89M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$33.59M	USD	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesCurrent`	-	USD	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesCurrent`	$59.75M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.04M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$8.00M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$169.51M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$171.38M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.60M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.37M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	71.95M	shares	Point-in-time
Total Assets	`Assets`	$173.97M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	62.25M	shares	Point-in-time
Total Assets	`Assets`	$171.89M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	71.95M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	62.25M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$863.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.90M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$5.62M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$4.11M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$4.97M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$8.53M	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized, 71,954,843 and 62,248,074 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized, 71,954,843 and 62,248,074 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$323.99M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$388.76M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$29.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-157.12M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-223.33M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$165.44M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$166.92M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$173.97M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$171.89M	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	-	USD	1 Quarter
Revenues	`Revenues`	-	USD	1 Quarter
Revenues	`Revenues`	-	USD	3 Qtrs
Revenues	`Revenues`	-	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$54.03M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$17.75M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$8.48M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$17.20M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$12.78M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$20.52M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$10.50M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.59M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$18.98M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$22.34M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$66.81M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$37.72M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-18.98M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-37.72M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-22.34M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-66.81M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$194.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$511.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$596.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$221.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-22.15M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-66.21M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-37.21M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-18.76M	USD	1 Quarter
Deemed dividend related to beneficial conversion feature of convertible preferred stock	`OtherPreferredStockDividendsAndAdjustments`	$49.45M	USD	1 Quarter
Deemed dividend related to beneficial conversion feature of convertible preferred stock	`OtherPreferredStockDividendsAndAdjustments`	$49.45M	USD	3 Qtrs
Deemed dividend related to beneficial conversion feature of convertible preferred stock	`OtherPreferredStockDividendsAndAdjustments`	-	USD	3 Qtrs
Deemed dividend related to beneficial conversion feature of convertible preferred stock	`OtherPreferredStockDividendsAndAdjustments`	-	USD	1 Quarter
Net Loss Attributable to Common Stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-68.21M	USD	1 Quarter
Net Loss Attributable to Common Stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-86.66M	USD	3 Qtrs
Net Loss Attributable to Common Stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-66.21M	USD	3 Qtrs
Net Loss Attributable to Common Stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-22.15M	USD	1 Quarter
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-1.06	USD	3 Qtrs
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-1.64	USD	3 Qtrs
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-1.15	USD	1 Quarter
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.35	USD	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	63,332.00	shares	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	52,963.00	shares	3 Qtrs
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	59,113.00	shares	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	62,697.00	shares	3 Qtrs

Cash Flow Statement 63 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-22.15M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-66.21M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-37.21M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-18.76M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$710.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$688.00K	USD	3 Qtrs
Amortization of discount (premium) on investments	`AmortizationOfDebtDiscountPremium`	$-69.00K	USD	3 Qtrs
Amortization of discount (premium) on investments	`AmortizationOfDebtDiscountPremium`	$19.00K	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$15.78M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$7.90M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$2.60M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$9.21M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$4.95M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$997.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-730.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.15M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.33M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$2.02M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-57.74M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-20.51M	USD	3 Qtrs
Purchase of short- term investments	`PaymentsToAcquireAvailableForSaleSecurities`	-	USD	3 Qtrs
Purchase of short- term investments	`PaymentsToAcquireAvailableForSaleSecurities`	$110.25M	USD	3 Qtrs
Maturities of short- term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$59.70M	USD	3 Qtrs
Maturities of short- term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$94.16M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.09M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$781.00K	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$58.62M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-16.87M	USD	3 Qtrs
Tax payments related to shares withheld for vested restricted stock awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.20M	USD	3 Qtrs
Tax payments related to shares withheld for vested restricted stock awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$354.00K	USD	3 Qtrs
Proceeds from the issuance of common stock upon exercise of warrants	`ProceedsFromWarrantExercises`	$388.00K	USD	3 Qtrs
Proceeds from the issuance of common stock upon exercise of warrants	`ProceedsFromWarrantExercises`	$879.00K	USD	3 Qtrs
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$2.55M	USD	3 Qtrs
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$478.00K	USD	3 Qtrs
Proceeds from the issuance of preferred stock and common stock, net	`ProceedsFromIssuanceOfCommonStock`	$53.80M	USD	Point-in-time
Proceeds from the issuance of preferred stock and common stock, net	`ProceedsFromIssuanceOfCommonStock`	$54.05M	USD	3 Qtrs
Proceeds from the issuance of preferred stock and common stock, net	`ProceedsFromIssuanceOfCommonStock`	$95.69M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$96.69M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$55.79M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$59.31M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$56.66M	USD	3 Qtrs
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$106.72M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$163.38M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$92.89M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$33.59M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$106.72M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$163.38M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$92.89M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$33.59M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Interest paid	`InterestPaidNet`	-	USD	3 Qtrs
Interest paid	`InterestPaidNet`	-	USD	3 Qtrs
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnShorttermInvestments`	$-29.00K	USD	3 Qtrs
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnShorttermInvestments`	$115.00K	USD	3 Qtrs
Acquisitions of property and equipment under accounts payable	`LeaseholdImprovementsPaidByLandlord`	$-155.00K	USD	3 Qtrs
Acquisitions of property and equipment under accounts payable	`LeaseholdImprovementsPaidByLandlord`	-	USD	3 Qtrs
Offering costs under accounts payable and accrued expenses	`OfferingCostsUnderAccountsPayableAndAccruedExpenses`	$235.00K	USD	3 Qtrs
Offering costs under accounts payable and accrued expenses	`OfferingCostsUnderAccountsPayableAndAccruedExpenses`	-	USD	3 Qtrs
Deemed dividend related to a beneficial conversion feature	`DeemedDividendRelatedToBeneficialConversionFeature`	-	USD	3 Qtrs
Deemed dividend related to a beneficial conversion feature	`DeemedDividendRelatedToBeneficialConversionFeature`	$49.45M	USD	3 Qtrs
Conversion of convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	$3.00K	USD	3 Qtrs
Conversion of convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	-	USD	3 Qtrs

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-22.15M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-66.21M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-37.21M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-18.76M	USD	1 Quarter
Unrealized (loss) gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$85.00K	USD	1 Quarter
Unrealized (loss) gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-29.00K	USD	3 Qtrs
Unrealized (loss) gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Unrealized (loss) gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$115.00K	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-37.09M	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-18.67M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-66.24M	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-22.15M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.